/Investor DB

Vensana Capital — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

Nyra Medicalnyramedical.comin𝕏Nov 2022✓ verified

Nyra Medical develops the CARLEN (Cardiac Leaflet Enhancer) system, a transcatheter single-leaflet device for repairing functional mitral regurgitation while preserving native valve function.

BiotechHealthtechMedical DevicesAtlanta, US

Dr. Murali Padala(Founder)Dr. Eric Sarin(Founder, Director)Dr. Kirthana Suresh(Founder)Sai Muralidhar Padala(Executive Officer, Director)Lori Chmura(CEO)inGowri Raman(Director)

Co-investorsBroadview VenturesEpidarex CapitalGRA Venture

Monteris Medicalmonteris.comin𝕏Sep 2022SEC filingmedium confidence

Monteris develops minimally invasive laser ablation technology (LITT) used to treat brain conditions including oncology tumors and drug-resistant epilepsy.

BiotechHealthtechMedical DevicesPlymouth, US

JAMES ERICKSON(Executive Officer)inMARTIN EMERSON(Executive Officer, Director)John Schellhorn(Executive Officer, Director, Promoter)inRobert K Davidson(Executive Officer)

BoardRICHARD EMMITT(Director)inGregory Barrett(Director)

Board seatKirk NielsenBill Hoffman· per SEC Form D · $13.7M raise · filed Sep 2022

Co-investorsThe Vertical Group

Moxemoxehealth.comin𝕏Jun 2022 · $30M

Moxe operates a platform for the secure exchange of clinical data between healthcare payers and providers, transforming that data into usable formats to support payment and operations use cases.

Data & InfrastructureDigital HealthHealthtechMadison, US

Daniel Wilson(Executive Officer, Director)

BoardGary J. Kurtzman, M.D.(Director)

Co-investorsGreat Oaks Venture CapitalApolloTrinity CapitalUPMC Enterprises

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.